BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

LD-2 disclosure · 4th Quarter - Report

INSULET CORPORATION

via MAGER & ASSOCIATES LLC

4th Quarter (Oct 1 - Dec 31) · 2017Posted Jan 18, 2018Filing document ↗LDA record ↗

Income$140Kfee reported

Client

Name: INSULET CORPORATION
Description: Medical device company
Location: Massachusetts · United States of America

Registrant

Firm: MAGER & ASSOCIATES LLC
Description: Consulting/public policy firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Medicare access and reimbursement for full range of insulin pumps
LobbyistsMIMI MAGER
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

INSULET CORPORATION — Lobbying — Receipts Report